Association of Childhood Exposure to Nitrogen Dioxide and Polygenic Risk Score for Schizophrenia With the Risk of Developing Schizophrenia.
Journal
JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235
Informations de publication
Date de publication:
01 11 2019
01 11 2019
Historique:
entrez:
2
11
2019
pubmed:
2
11
2019
medline:
17
6
2020
Statut:
epublish
Résumé
Schizophrenia is a highly heritable psychiatric disorder, and recent studies have suggested that exposure to nitrogen dioxide (NO2) during childhood is associated with an elevated risk of subsequently developing schizophrenia. However, it is not known whether the increased risk associated with NO2 exposure is owing to a greater genetic liability among those exposed to highest NO2 levels. To examine the associations between childhood NO2 exposure and genetic liability for schizophrenia (as measured by a polygenic risk score), and risk of developing schizophrenia. Population-based cohort study including individuals with schizophrenia (International Statistical Classification of Diseases and Related Health Problems, Tenth Revision code F20) and a randomly selected subcohort. Using national registry data, all individuals born in Denmark between May 1, 1981, and December 31, 2002, were followed up from their 10th birthday until the first occurrence of schizophrenia, emigration, death, or December 31, 2012, whichever came first. Statistical analyses were conducted between October 24, 2018, and June 17, 2019. Individual exposure to NO2 during childhood estimated as mean daily exposure to NO2 at residential addresses from birth to the 10th birthday. Polygenic risk scores were calculated as the weighted sum of risk alleles at selected single-nucleotide polymorphisms based on genetic material obtained from dried blood spot samples from the Danish Newborn Screening Biobank and on the Psychiatric Genomics Consortium genome-wide association study summary statistics file. The main outcome was schizophrenia. Weighted Cox proportional hazards regression models were fitted to estimate adjusted hazard ratios (AHRs) for schizophrenia with 95% CIs according to the exposures. Of a total of 23 355 individuals, 11 976 (51.3%) were male and all had Danish-born parents. During the period of the study, 3531 were diagnosed with schizophrenia. Higher polygenic risk scores were correlated with higher childhood NO2 exposure (ρ = 0.0782; 95% CI, 0.065-0.091; P < .001). A 10-μg/m3 increase in childhood daily NO2 exposure (AHR, 1.23; 95% CI, 1.15-1.32) and a 1-SD increase in polygenic risk score (AHR, 1.29; 95% CI, 1.23-1.35) were independently associated with increased schizophrenia risk. These findings suggest that the apparent association between NO2 exposure and schizophrenia is only slightly confounded by a higher polygenic risk score for schizophrenia among individuals living in areas with greater NO2. The findings demonstrate the utility of including polygenic risk scores in epidemiologic studies.
Identifiants
pubmed: 31675084
pii: 2753791
doi: 10.1001/jamanetworkopen.2019.14401
pmc: PMC6827271
doi:
Substances chimiques
Air Pollutants
0
Nitrogen Dioxide
S7G510RUBH
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1914401Références
Biol Psychiatry. 2018 Nov 1;84(9):684-691
pubmed: 29807621
Schizophr Res. 2017 Jun;184:122-127
pubmed: 27939829
Lancet. 2016 Jul 2;388(10039):86-97
pubmed: 26777917
Scand J Public Health. 2011 Jul;39(7 Suppl):95-8
pubmed: 21775363
J Inherit Metab Dis. 2007 Aug;30(4):530-6
pubmed: 17632694
J Toxicol. 2012;2012:782462
pubmed: 22523490
Nat Genet. 2013 Oct;45(10):1150-9
pubmed: 23974872
Psychol Med. 2018 Jan;48(2):305-314
pubmed: 28659227
Epidemiol Rev. 2008;30:67-76
pubmed: 18480098
Psychiatry Res. 2019 Aug;278:146-150
pubmed: 31200193
Lifetime Data Anal. 2000 Mar;6(1):39-58
pubmed: 10763560
Schizophr Res. 2015 Oct;168(1-2):204-8
pubmed: 26341580
JAMA Psychiatry. 2014 May;71(5):573-81
pubmed: 24806211
Gigascience. 2015 Feb 25;4:7
pubmed: 25722852
Cell. 2012 Mar 16;148(6):1223-41
pubmed: 22424231
Trends Neurosci. 2009 Sep;32(9):506-16
pubmed: 19716187
Psychol Med. 2018 May;48(7):1201-1208
pubmed: 28942743
JAMA Psychiatry. 2018 Sep 1;75(9):901-910
pubmed: 29936532
Nature. 2014 Jul 24;511(7510):421-7
pubmed: 25056061
Schizophr Res. 2012 Feb;134(2-3):246-52
pubmed: 22108675
JAMA Psychiatry. 2019 Jun 1;76(6):614-623
pubmed: 30916743
Schizophr Res. 2019 Apr;206:284-290
pubmed: 30446270
Dan Med J. 2013 Feb;60(2):A4578
pubmed: 23461991
Mol Psychiatry. 2014 Mar;19(3):325-33
pubmed: 23358160
Schizophr Bull. 2016 May;42(3):542-9
pubmed: 26392629
Nat Genet. 2018 Mar;50(3):381-389
pubmed: 29483656
Nat Rev Genet. 2008 Jul;9(7):527-40
pubmed: 18560438
Scand J Public Health. 2011 Jul;39(7 Suppl):91-4
pubmed: 21775362
PLoS Genet. 2006 Dec;2(12):e190
pubmed: 17194218
Scand J Public Health. 2011 Jul;39(7 Suppl):54-7
pubmed: 21775352
Scand J Public Health. 2011 Jul;39(7 Suppl):22-5
pubmed: 21775345
Biol Psychiatry. 2016 Oct 15;80(8):609-16
pubmed: 27364036
Am J Hum Genet. 2007 Sep;81(3):559-75
pubmed: 17701901
Nat Commun. 2018 Dec 13;9(1):5296
pubmed: 30546018
Hum Hered. 2018;83(4):210-224
pubmed: 30865946
Am J Hum Genet. 2015 Oct 1;97(4):576-92
pubmed: 26430803
Mol Psychiatry. 2018 Jan;23(1):6-14
pubmed: 28924187
Nat Genet. 2006 Aug;38(8):904-9
pubmed: 16862161
Schizophr Bull. 2013 Sep;39(5):955-9
pubmed: 23907349
Nat Genet. 2012 Feb 19;44(3):247-50
pubmed: 22344220
Genet Epidemiol. 2012 Apr;36(3):214-24
pubmed: 22714935
JAMA Psychiatry. 2015 Jul;72(7):635-41
pubmed: 25830477